Indices

Indxx Global Generics & New Pharma Index TR

The Indxx Global Generics & New Pharma Index provides exposure to the 100 largest companies involved in manufacturing Generics, SuperGenerics, Biobetters and Biosimilars, and providing API manufacturing, CMO and CRO services to the pharmaceutical industry.

Charting

Index Characteristics

Base Date 03/18/2005
No. of Constituents 40
Dividend Yield
*
0.91%
52 Week High/Low
**
3743/3113
* Trailing 12 months data for current year portfolio
** Trailing 12 months


Top 5 Constituents

Constituent ISIN Weight
Teva Pharmaceutical-sp Adr US8816242098 7.17%
Quintiles Ims Holdings Inc US74876Y1010 6.43%
Mylan Nv NL0011031208 6.35%
Sun Pharmaceutical Indus INE044A01036 6.16%
Lonza Group Ag CH0013841017 4.94%

Risk & Return Statistics

Statistic QTD YTD 1 Year 3 Year SBD
Beta
1
- 0.74 0.78 0.88 0.83
Correlation
1
- 0.57 0.66 0.80 0.83
Returns
2
-6.29% 0.41% -14.73% 0.69% 9.78%
Deviation - 10.08% 11.47% 14.06% 14.15%
1w.r.t.S&P Global 1200 Health Care(PR) Index
2All returns for period greater than 1 year are annualized